Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
Foley, Paul W X, Stegemann, Berthold, Ng, Kelvin, Ramachandran, Sud, Proudler, Anthony, Frenneaux, Michael P, Ng, Leong L and Leyva, Francisco (2009) Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. European Heart Journal, 30 (22). pp. 2749-2757. ISSN 0195-668X
Full text not available from this repository. (Request a copy)Abstract
The aim of this study was to determine whether growth differentiation factor-15 (GDF-15) predicts mortality and morbidity after cardiac resynchronization therapy (CRT). Growth differentiation factor-15, a transforming growth factor-beta-related cytokine which is up-regulated in cardiomyocytes via multiple stress pathways, predicts mortality in patients with heart failure treated pharmacologically.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | aged,area under curve,biological markers,cardiac pacing, artificial,defibrillators, implantable,enzyme-linked immunosorbent assay,female,growth differentiation factor 15,heart failure,humans,male,middle aged,natriuretic peptide, brain,peptide fragments,risk factors,survival analysis |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Related URLs: | |
Depositing User: | Pure Connector |
Date Deposited: | 17 Mar 2015 11:20 |
Last Modified: | 06 May 2022 01:59 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/52760 |
DOI: | 10.1093/eurheartj/ehp300 |
Actions (login required)
![]() |
View Item |